Ethex issues voluntary recall
Ethex Corporation has issued a voluntary recall on certain products, expanding it to the retail level. The company is taking this action as a precautionary measure because the products may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practice (cGMP).
The expanded recall includes the following products:
-Morphine sulfate extended-release tablets 15mg, 30mg
-Morphine sulfate immediate-release tablets 15mg and 30mg
-Dextroamphetamine sulfate tablets 5mg and 10mg
-Isosorbide mononitrate extended-release tablets 30mg, 60mg and 120mg
-Propafenone HCl tablets 150mg, 225mg and 300 mg.
For more information call (800) 748-1472 or visit www.kvpharmaceutical.com.